Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec;12(1):8724-8737.
doi: 10.1080/21655979.2021.1978196.

Long non-coding RNA HOXA-AS3 promotes cell proliferation of oral squamous cell carcinoma through sponging microRNA miR-218-5p

Affiliations

Long non-coding RNA HOXA-AS3 promotes cell proliferation of oral squamous cell carcinoma through sponging microRNA miR-218-5p

Yue Zhao et al. Bioengineered. 2021 Dec.

Abstract

Increasing evidence demonstrated long non-coding RNAs (lncRNAs) play important roles in the occurrence and development of oral squamous cell carcinoma (OSCC). This study aimed to explore the role and molecular mechanism of lncRNA HOXA-AS3 in the progression of OSCC. Here, we found that the expression of lncRNA HOXA-AS3 was upregulated in OSCC tissues and cell lines compared with the para-cancerous tissues and normal human oral keratinocyte (NHOK), respectively. Inhibition of HOXA-AS3 significantly inhibited the proliferation and colony formation of OSCC cells. Further, the luciferase reporter assay showed that HOXA-AS3 was directly bound to miR-218-5p. Moreover, the expression of miR-218-5p was negatively regulated by HOXA-AS3, and miR-218-5p could inhibit the expression of collagen type I alpha1 (COL1A1) and lysophosphatidylcholine acyltransferase 1 (LPCAT1). In addition, silencing miR-218-5p reversed the inhibitory effect of HOXA-AS3 knockdown on the proliferative potential of OSCC cells. In summary, our study illustrated that HOXA-AS3 promoted cancer cell proliferation in OSCC, possibly by sponging miR-218-5p for the first time, which provides a new target or a potential diagnostic biomarker for OSCC.

Keywords: HOXA-AS3; LncRNA; Oral squamous cell carcinoma; miR-218-5p; proliferation.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Figure 1.
Figure 1.
HOXA-AS3 expression is upregulated in OSCC tissues and cell lines. (a) The expression of HOXA-AS3 in OSCC tissues and para-cancerous tissues was measured using qRT-PCR. (b) Expression levels of HOXA-AS3 in NHOK and OSCC cell lines (TSCCA, CAL-27, SCC-9, and Tca8113) were detected via qRT-PCR. (c) The Kaplan-Meier survival curve indicated that the prognosis of patients in HOXA-AS3 high-expression group was significantly worse than that of patients in HOXA-AS3 low-expression group. *P < 0.05, **P < 0.01
Figure 2.
Figure 2.
HOXA-AS3 knockdown inhibited OSCC cell proliferation and colony formation in vitro and in vivo. (a) Transfection efficacy of sh-HOXA-AS3 in SCC-9 and CAL-27 cells. (b, c) Cell Counting Kit-8 assay showed that HOXA-AS3 knockdown inhibited cell proliferation in SCC-9 and CAL-27 cells. (d) Colony formation assay showed that HOXA-AS3 knockdown significantly reduced the number of colonies. *P < 0.05, **P < 0.01
Figure 3.
Figure 3.
HOXA-AS3 directly interacted with miR-218-5p. (a) Predicted binding of human miR-218-5p with the wild-type 3ʹUTR region of HOXA-AS3 mRNA and a mutated 3ʹUTR of HOXA-AS3. (b, c) Luciferase reporter gene assay verified that HOXA-AS3 could directly bind to miR-218-5p in SCC-9 and CAL-27 cells. (d, e) SCC-9 and CAL-27 cells were transfected with miR-218-5p mimics or control, followed by the measurement of HOXA-AS3 mRNA enrichment with anti-Ago2 by qRT-PCR, and anti-IgG used as control. *P < 0.05, **P < 0.01
Figure 4.
Figure 4.
MiR-218-5p was downregulated in OSCC tissues and cells and inversely correlated with HOXA-AS3 expression. (a) The expression of miR-218-5p in OSCC cell lines and NHOK was detected by qRT-PCR. (b) The expression of miR-218-5p in OSCC tissues and para-cancerous tissues was detected by qRT-PCR. (c) HOXA-AS3 and miR-218-5p expression level was negatively correlated in OSCC tissues (r = −0.759, P < 0.01, n = 38). (d) qRT-PCR was used to measure the expression level of miR-218-5p after HOXA-AS3 knockdown in OSCC cell lines. *P < 0.05, **P < 0.01
Figure 5.
Figure 5.
Overexpression of miR-218-5p inhibited the proliferation of OSCC cells. (a) Transfection efficacy of miR-218-5p mimics in SCC-9 and CAL-27 cells. (b, c) Cell Counting Kit-8 assay showed that overexpression of miR-218-5p inhibited cell proliferation in OSCC cells. (d) Colony formation assay showed that overexpression of miR-218-5p significantly reduced the number of colonies. *P < 0.05, **P < 0.01
Figure 6.
Figure 6.
MiR-218-5p inhibited COL1A1 and LPCAT1 in OSCC cells. (a) The poteintial targeted mRNAs of miR-218-5p were predicted by PicTar, miRanda and TargetScan online databases. (b) Volcano plot showing the DEGs identified from GSE138206. X axis represents log transformed P value, and Y axis indicates the mean expression differences of genes between OSCC samples and normal samples. (c) qRT-PCR was used to measure the expression of COL1A1 after miR-218-5p overexpression in OSCC-9 cells. (d) qRT-PCR was used to measure the expression of LPCAT1 after miR-218-5p overexpression in OSCC cells. *P < 0.05, **P < 0.01, ***P < 0.001
Figure 7.
Figure 7.
LncRNA HOXA-AS3 promoted OSCC development through regulating miR-218-5p. (a, b) The expression level of HOXA-AS3 in cells co-transfected with sh-HOXA-AS3 and anti-miR-218-5p was detected by qRT-PCR. (c-f) The inhibited proliferation of SCC-9 and CAL-27 cells by HOXA-AS3 knockdown was reversed by anti-miR-218-5p. *P < 0.05, **P < 0.01

Similar articles

Cited by

References

    1. Nagao T, Warnakulasuriya S.. Screening for oral cancer: future prospects, research and policy development for Asia. Oral Oncol. 2020;105:104632. - PubMed
    1. Shrestha AD, Vedsted P.. Prevalence and incidence of oral cancer in low- and middle-income countries: a scoping review. Eur J Cancer Care (Engl). 2020;29(2):e13207. - PubMed
    1. Almangush A, Mäkitie AA, Triantafyllou A, et al. Staging and grading of oral squamous cell carcinoma: an update. Oral Oncol. 2020;107:104799. - PubMed
    1. Wang W, Adeoye J, Thomson P. Statistical profiling of oral cancer and the prediction of outcome. J Oral Pathol Med. 2021;50(1):39–46. - PubMed
    1. Zhang X, Cui Y, Ding X, et al. Analysis of mRNA‑lncRNA and mRNA‑lncRNA-pathway co‑expression networks based on WGCNA in developing pediatric sepsis. Bioengineered. 2021;12(1):1457–1470. - PMC - PubMed

MeSH terms